0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Prostate Cancer
 1-20 of 300 Articles
JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Ellen S. de Morrée, MSc; Nicholas J. Vogelzang, MD; Daniel P. Petrylak, MD; et al.
JAMA Oncol. Published online August 25, 2016. doi:10.1001/jamaoncol.2016.3000
Includes: Supplemental Content

JAMA Oncology | 
Viewpoint |  FREE ONLINE FIRST
Maha Hussain, MD; Mario Eisenberger, MD
JAMA Oncol. Published online August 25, 2016. doi:10.1001/jamaoncol.2016.2650

JAMA Oncology | 
Viewpoint |  FREE ONLINE FIRST
Laurence Klotz, MD, FRCSC, CM; Celestia S, Higano, MD
JAMA Oncol. Published online August 25, 2016. doi:10.1001/jamaoncol.2016.3138

JAMA Oncology | 
Research Letter |  ONLINE FIRST
Ahmedin Jemal, DVM, PhD; Jiemin Ma, PhD; Rebecca Siegel, MPH; et al.
JAMA Oncol. Published online August 18, 2016. doi:10.1001/jamaoncol.2016.2667

JAMA Oncology | 
Viewpoint |  ONLINE FIRST
Robert Dreicer, MD, MS
JAMA Oncol. Published online August 18, 2016. doi:10.1001/jamaoncol.2016.3325

JAMA Oncology | 
Cancer Care Chronicles | 
Neha Vapiwala, MD
JAMA Oncol. 2016;2(8):996-998. doi:10.1001/jamaoncol.2015.6566.

JAMA Internal Medicine | 
Teachable Moment | 
Justin C. Laracy, MD; Ricky Regalbuto, MD; Brian L. Block, MD
JAMA Intern Med. 2016;176(8):1064-1065. doi:10.1001/jamainternmed.2016.2525.

JAMA Oncology | 
Research Letter |  ONLINE FIRST
Neige M. Y. Journy, PhD; Lindsay M. Morton, PhD; Ruth A. Kleinerman, MPH; et al.
JAMA Oncol. Published online July 14, 2016. doi:10.1001/jamaoncol.2016.1368

JAMA Surgery | 
Research Letter | 
Gregory B. Auffenberg, MD; Khurshid R. Ghani, MBChB, MS; Zaojun Ye, MS; et al.
JAMA Surg. 2016;151(7):680-682. doi:10.1001/jamasurg.2016.0077.

JAMA Oncology | 
From The JAMA Network | 
Ruth Etzioni, PhD; Roman Gulati, MS
JAMA Oncol. 2016;2(7):955-956. doi:10.1001/jamaoncol.2015.6310.

JAMA Oncology | 
Invited Commentary | 
Andrew J. Vickers, PhD
JAMA Oncol. 2016;2(7):899-900. doi:10.1001/jamaoncol.2015.6276.

JAMA Oncology | 
Original Investigation | 
Joshua A. Roth, PhD, MHA; Roman Gulati, MS; John L. Gore, MD; et al.
JAMA Oncol. 2016;2(7):890-898. doi:10.1001/jamaoncol.2015.6275.
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Hiten D. Patel, MD, MPH; Heather J. Chalfin, MD; H. Ballentine Carter, MD
JAMA Oncol. 2016;2(7):867-868. doi:10.1001/jamaoncol.2016.0170.

JAMA Oncology | 
Original Investigation | 
James McKiernan, MD; Michael J. Donovan, PhD, MD; Vince O’Neill, MD; et al.
JAMA Oncol. 2016;2(7):882-889. doi:10.1001/jamaoncol.2016.0097.
Includes: Supplemental Content

JAMA Oncology | 
Research Letter |  ONLINE FIRST
Aaron D. Falchook, MD; Ramsankar Basak, PhD; Jahan J. Mohiuddin, MS; et al.
JAMA Oncol. Published online June 30, 2016. doi:10.1001/jamaoncol.2016.1143

JAMA | 
Viewpoint | 
Jim C. Hu, MD, MPH; Aaron Laviana, MD; Art Sedrakyan, MD, PhD
JAMA. 2016;315(24):2659-2660. doi:10.1001/jama.2016.5002.

JAMA Oncology | 
Research Letter |  ONLINE FIRST
Matthew J. Maurice, MD; Simon P. Kim, MD, MPH; Robert Abouassaly, MD, MS
JAMA Oncol. Published online June 23, 2016. doi:10.1001/jamaoncol.2016.1785

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
R. B. Montgomery, MD; Stephen R. Plymate, MD
JAMA Oncol. Published online June 04, 2016. doi:10.1001/jamaoncol.2016.2360

JAMA Oncology | 
Original Investigation |  Open Access ONLINE FIRST
Howard I. Scher, MD; David Lu, PhD; Nicole A. Schreiber, BA; et al.
JAMA Oncol. Published online June 04, 2016. doi:10.1001/jamaoncol.2016.1828
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Alexander W. Wyatt, DPhil; Arun A. Azad, MD; Stanislav V. Volik, PhD; et al.
JAMA Oncol. Published online May 05, 2016. doi:10.1001/jamaoncol.2016.0494
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered A Post hoc Analysis of the Mainsail Study
Ellen S. de Morrée, MSc; Nicholas J. Vogelzang, MD; Daniel P. Petrylak, MD; et al.
JAMA Oncology
Viewpoint  | 
Intermittent Androgen Deprivation Primum Non Nocere—“First Do NO Harm”
Maha Hussain, MD; Mario Eisenberger, MD
JAMA Oncology
Viewpoint  | 
Intermittent Androgen Deprivation Therapy—An Important Treatment Option for Prostate Cancer
Laurence Klotz, MD, FRCSC, CM; Celestia S, Higano, MD
JAMA Oncology
Research Letter  | 
Prostate Cancer Incidence Rates 2 Years After the US Preventive Services Task Force Recommendations Against Screening
Ahmedin Jemal, DVM, PhD; Jiemin Ma, PhD; Rebecca Siegel, MPH; et al.